BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1542847)

  • 1. Brachytherapy of choroidal melanomas.
    Brady LW; Hernandez JC
    Strahlenther Onkol; 1992 Feb; 168(2):61-5. PubMed ID: 1542847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten-year follow-up of fellow eyes of patients enrolled in Collaborative Ocular Melanoma Study randomized trials: COMS report no. 22.
    Collaborative Ocular Melanoma Study Group
    Ophthalmology; 2004 May; 111(5):966-76. PubMed ID: 15121376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palladium-103 plaque radiotherapy for choroidal melanoma: results of a 7-year study.
    Finger PT; Berson A; Szechter A
    Ophthalmology; 1999 Mar; 106(3):606-13. PubMed ID: 10080222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas.
    Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):392-400. PubMed ID: 15990248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of iodine 125 plaque radiotherapy after initial observation of suspected small choroidal melanomas: a pilot study.
    Sobrin L; Schiffman JC; Markoe AM; Murray TG
    Ophthalmology; 2005 Oct; 112(10):1777-83. PubMed ID: 16095708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27.
    Collaborative Ocular Melanoma Study Group
    Ophthalmology; 2007 Jul; 114(7):1363-71. PubMed ID: 17337065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Iodine-125-brachytherapy of malignant choroid melanoma. II: Long-term functional outcome].
    Kreissig I; Rose D; Simader E
    Klin Monbl Augenheilkd; 1996 Jul; 209(1):7-12. PubMed ID: 8965481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular complications following I-125 brachytherapy for choroidal melanoma.
    Wen JC; Oliver SC; McCannel TA
    Eye (Lond); 2009 Jun; 23(6):1254-68. PubMed ID: 19265865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24.
    Hawkins BS;
    Am J Ophthalmol; 2004 Dec; 138(6):936-51. PubMed ID: 15629284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transscleral resection versus iodine brachytherapy for choroidal malignant melanomas 6 millimeters or more in thickness: a matched case-control study.
    Kivelä T; Puusaari I; Damato B
    Ophthalmology; 2003 Nov; 110(11):2235-44. PubMed ID: 14597535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual outcome, local tumour control, and eye preservation after 106Ru/Rh brachytherapy for choroidal melanoma.
    Isager P; Ehlers N; Urbak SF; Overgaard J
    Acta Oncol; 2006; 45(3):285-93. PubMed ID: 16644571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patients.
    Finger PT; Chin KJ; Duvall G;
    Ophthalmology; 2009 Apr; 116(4):790-6, 796.e1. PubMed ID: 19243829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Curietherapy using a ruthenium and iridium disk in the treatment of choroid melanoma].
    Gérard JP; Grange JD; Romestaing P; Sentenac I; De Laroche G; Montbarbon X; Mahe M; Salerno N; Baude JP; Bonnet M
    Ann Radiol (Paris); 1989; 32(2):107-11. PubMed ID: 2757334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3.
    Melia M; Moy CS; Reynolds SM; Hayman JA; Murray TG; Hovland KR; Earle JD; Kurinij N; Dong LM; Miskala PH; Fountain C; Cella D; Mangione CM;
    Arch Ophthalmol; 2006 Feb; 124(2):226-38. PubMed ID: 16476893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retrospective analysis of ruthenium-106 brachytherapy for small and medium-sized malignant melanoma of the posterior choroid].
    Stoffelns BM; Kutzner J; Jochem T
    Klin Monbl Augenheilkd; 2002 Apr; 219(4):216-20. PubMed ID: 12022004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of choroid melanoma with contact curietherapy using ruthenium 106].
    Muller RP; Busse H; Kroll P; Gast E
    J Fr Ophtalmol; 1985; 8(10):639-43. PubMed ID: 3833880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.